GlaxoSmithKline Searching For Hit Drugs Pours $95M Into DNA Dark Matter

July 08, 2015 | GlaxoSmithKline is investing $95 million in a nonprofit research center in Seattle called the Altius Institute for Biomedical Sciences, focusing on the "dark matter" of the genome. Forbes